ezetimibe has been researched along with ursodeoxycholic acid in 7 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (ursodeoxycholic acid) | Trials (ursodeoxycholic acid) | Recent Studies (post-2010) (ursodeoxycholic acid) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 4,592 | 626 | 1,561 |
| Protein | Taxonomy | ezetimibe (IC50) | ursodeoxycholic acid (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| Sodium/bile acid cotransporter | Homo sapiens (human) | 3.6 | |
| M1-family alanyl aminopeptidase | Plasmodium falciparum 3D7 | 2.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Enjoji, M; Kato, M; Kohjima, M; Kotoh, K; Machida, K; Matsunaga, K; Nakamuta, M; Nakashima, M | 1 |
| de Bari, O; Garruti, G; Liu, KJ; Neuschwander-Tetri, BA; Portincasa, P; Wang, DQ; Wang, HH | 1 |
| Barrett, TA; Bradford, EM; Graf, GA; Horn, J; Leggas, M; Li, J; Liu, X; Pijut, SS; Wang, Y | 1 |
| Kanno, K; Kishikawa, N; Mizooka, M; Sugiyama, A; Tazuma, S; Yokobayashi, K | 1 |
| Habe, K; Higashiyama, A; Mizutani, H; Omoto, Y; Yamanaka, K; Yokoyama, T | 1 |
2 review(s) available for ezetimibe and ursodeoxycholic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol.
Topics: Anticholesteremic Agents; Azetidines; Cholagogues and Choleretics; Cholesterol; Ezetimibe; Gallstones; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Absorption; Lipid Metabolism; Liver; Ursodeoxycholic Acid | 2013 |
5 other study(ies) available for ezetimibe and ursodeoxycholic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease.
Topics: Adipokines; Adult; Anticholesteremic Agents; Azetidines; Carbohydrates; Cholesterol; Ezetimibe; Fatty Liver; Female; Humans; Liver; Male; Membrane Proteins; Membrane Transport Proteins; Middle Aged; Obesity; Ursodeoxycholic Acid | 2010 |
The combination of ezetimibe and ursodiol promotes fecal sterol excretion and reveals a G5G8-independent pathway for cholesterol elimination.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 5; ATP Binding Cassette Transporter, Subfamily G, Member 8; ATP-Binding Cassette Transporters; Bile Acids and Salts; Biliary Tract; Biological Transport; Cholesterol; Dose-Response Relationship, Drug; Drug Synergism; Ezetimibe; Feces; Female; Gene Knockout Techniques; Intestinal Mucosa; Intestines; Lipoproteins; Male; Mice; Protein Multimerization; Protein Structure, Quaternary; Ursodeoxycholic Acid | 2015 |
Long-term administration of a Niemann-Pick C1-like 1 inhibitor, ezetimibe, does not worsen bile lithogenicity in dyslipidemic patients with hepatobiliary diseases.
Topics: Anticholesteremic Agents; Bile; Cholesterol; Dyslipidemias; Ezetimibe; Fatty Liver; Female; Gallstones; Humans; Lipid Metabolism; Lipoproteins; Male; Middle Aged; Phytosterols; Ursodeoxycholic Acid | 2016 |
Flutamide-induced photoleukomelanoderma.
Topics: Administration, Cutaneous; Aged; Androgen Antagonists; Benzimidazoles; Biopsy; Biphenyl Compounds; Bisoprolol; Clopidogrel; Drug Eruptions; Eicosapentaenoic Acid; Ezetimibe; Flutamide; Glucocorticoids; Humans; Male; Patch Tests; Photosensitivity Disorders; Prostatic Neoplasms; Skin Pigmentation; Sunlight; Tetrazoles; Ticlopidine; Ursodeoxycholic Acid; Withholding Treatment | 2016 |